Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death
- PMID: 23178451
- DOI: 10.1016/j.canlet.2012.11.006
Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death
Abstract
2'-Benzoyloxycinnamaldehyde (BCA) induces apoptosis in human cancer cells through ROS generation. BCA upregulates proapoptotic genes such as activating transcription factor 3 (ATF3), NSAID-activated gene 1 protein (NAG-1), and growth arrest and DNA-damage-inducible protein alpha (GADD45A) in prostate cancer cells. These genes are known to be induced by transcription factor early growth response protein 1 (EGR1). BCA induces significant EGR1 upregulation, while EGR1 knockdown decreases the induction of these genes with concurrent alleviation of cell death by BCA. Antioxidant glutathione pretreatment with BCA removes EGR1 expression increase, suggesting that EGR1 upregulation is dependent on oxidative stress generated by BCA. In prostate cancer cells, EGR1 localizes in the cytoplasm; however, BCA remarkably upregulates EGR1 nuclear translocalization, suggesting its possible effect as a transcriptional activator. BCA induces transient upregulation of importin-7 (IPO7) which is critical for EGR1 nuclear translocation, and IPO7 knockdown led to a significant decrease in chemosensitivity to BCA. Taken together, our findings suggest that BCA induces prostate cancer cell death via EGR1 upregulation and nuclear translocalization, followed by activation of proapoptotic target genes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer.Cancer Lett. 2014 Jul 10;349(1):35-44. doi: 10.1016/j.canlet.2014.03.025. Epub 2014 Apr 1. Cancer Lett. 2014. PMID: 24704156
-
E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.Cancer Res. 2009 Mar 15;69(6):2324-31. doi: 10.1158/0008-5472.CAN-08-4113. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276347
-
2'-Benzoyloxycinnamaldehyde-mediated DJ-1 upregulation protects MCF-7 cells from mitochondrial damage.Biol Pharm Bull. 2012;35(6):895-902. doi: 10.1248/bpb.35.895. Biol Pharm Bull. 2012. PMID: 22687481
-
Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival.Tumour Biol. 2002 Mar-Apr;23(2):93-102. doi: 10.1159/000059711. Tumour Biol. 2002. PMID: 12065847 Review.
-
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.Cancer Gene Ther. 2006 Feb;13(2):115-24. doi: 10.1038/sj.cgt.7700896. Cancer Gene Ther. 2006. PMID: 16138117 Free PMC article. Review.
Cited by
-
Extensive cargo identification reveals distinct biological roles of the 12 importin pathways.Elife. 2017 Jan 24;6:e21184. doi: 10.7554/eLife.21184. Elife. 2017. PMID: 28117667 Free PMC article.
-
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians.Sci Rep. 2016 Dec 5;6:38411. doi: 10.1038/srep38411. Sci Rep. 2016. PMID: 27917918 Free PMC article.
-
Chitotriose Enhanced Antitumor Activity of Doxorubicin through Egr1 Upregulation in MDA-MB-231 Cells.Mar Drugs. 2023 Dec 29;22(1):26. doi: 10.3390/md22010026. Mar Drugs. 2023. PMID: 38248651 Free PMC article.
-
Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers.Int J Clin Exp Pathol. 2014 May 15;7(6):2883-93. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25031707 Free PMC article.
-
Activation of Egr-1 in human lung epithelial cells exposed to silica through MAPKs signaling pathways.PLoS One. 2013 Jul 18;8(7):e68943. doi: 10.1371/journal.pone.0068943. Print 2013. PLoS One. 2013. PMID: 23874821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
